Description:
Vastarel MR 35mg is a modified-release tablet containing trimetazidine dihydrochloride, used as an adjunct therapy for the symptomatic treatment of stable angina pectoris in patients inadequately controlled by or intolerant to first-line antianginal therapies.
Prescription:
- Prescription-only medication.
Dosage:
- Adults: One tablet (35 mg) taken orally twice daily, preferably during meals in the morning and evening.
- Elderly or patients with moderate renal impairment: Dosage adjustment may be necessary; consult a healthcare provider.
- Children: Not recommended.
Therapeutic Category:
- Antianginal agent (metabolic modulator).
Active Ingredients/Composition:
- Active Ingredient: Trimetazidine dihydrochloride 35 mg.
Variant:
- Modified-release film-coated tablet.
Consume Type:
Directions/Usage:
- Take one tablet orally twice daily, preferably during meals in the morning and evening.
- Swallow the tablet whole; do not chew or crush.
- Adhere strictly to the prescribed dosage and schedule provided by your healthcare professional.
Common Side Effects:
- Dizziness
- Headache
- Abdominal pain
- Diarrhea
- Indigestion
- Nausea
- Vomiting
- Rash
- Itching
- Hives
- Feeling of weakness
Package Type:
- Typically supplied in boxes containing 30 modified-release film-coated tablets.
Storage Advice:
- Store below 30°C (86°F).
- Keep in the original package to protect from moisture.
- Keep out of reach of children.
Safety Advice:
- Not recommended for use in patients with Parkinson’s disease or Parkinsonian symptoms.
- Should not be used in patients with severe renal impairment.
- Discontinue use if movement disorders such as Parkinsonian symptoms occur.
- Use with caution in elderly patients and those with moderate renal impairment; dosage adjustment may be necessary.
Product Substitutes:
- Axinol 20mg Tablet
- Metazine 20mg Tablet
- Vastarel 20mg Tablets
- Vastarel XR 80mg Prolonged-release Capsules
Manufacturer/Marketer:
Country of Origin:
Reviews
There are no reviews yet.